Fingerprint
Dive into the research topics of 'Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically